Global Painful Diabetic Neuropathy Drug Market Research Report 2023

Global Painful Diabetic Neuropathy Drug Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Painful Diabetic Neuropathy Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Painful Diabetic Neuropathy Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Painful Diabetic Neuropathy Drug Market Perspective (2018-2029)
2.2 Painful Diabetic Neuropathy Drug Growth Trends by Region
2.2.1 Global Painful Diabetic Neuropathy Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Painful Diabetic Neuropathy Drug Historic Market Size by Region (2018-2023)
2.2.3 Painful Diabetic Neuropathy Drug Forecasted Market Size by Region (2024-2029)
2.3 Painful Diabetic Neuropathy Drug Market Dynamics
2.3.1 Painful Diabetic Neuropathy Drug Industry Trends
2.3.2 Painful Diabetic Neuropathy Drug Market Drivers
2.3.3 Painful Diabetic Neuropathy Drug Market Challenges
2.3.4 Painful Diabetic Neuropathy Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Painful Diabetic Neuropathy Drug Players by Revenue
3.1.1 Global Top Painful Diabetic Neuropathy Drug Players by Revenue (2018-2023)
3.1.2 Global Painful Diabetic Neuropathy Drug Revenue Market Share by Players (2018-2023)
3.2 Global Painful Diabetic Neuropathy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Painful Diabetic Neuropathy Drug Revenue
3.4 Global Painful Diabetic Neuropathy Drug Market Concentration Ratio
3.4.1 Global Painful Diabetic Neuropathy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Painful Diabetic Neuropathy Drug Revenue in 2022
3.5 Painful Diabetic Neuropathy Drug Key Players Head office and Area Served
3.6 Key Players Painful Diabetic Neuropathy Drug Product Solution and Service
3.7 Date of Enter into Painful Diabetic Neuropathy Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Painful Diabetic Neuropathy Drug Breakdown Data by Type
4.1 Global Painful Diabetic Neuropathy Drug Historic Market Size by Type (2018-2023)
4.2 Global Painful Diabetic Neuropathy Drug Forecasted Market Size by Type (2024-2029)
5 Painful Diabetic Neuropathy Drug Breakdown Data by Application
5.1 Global Painful Diabetic Neuropathy Drug Historic Market Size by Application (2018-2023)
5.2 Global Painful Diabetic Neuropathy Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Painful Diabetic Neuropathy Drug Market Size (2018-2029)
6.2 North America Painful Diabetic Neuropathy Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023)
6.4 North America Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Painful Diabetic Neuropathy Drug Market Size (2018-2029)
7.2 Europe Painful Diabetic Neuropathy Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023)
7.4 Europe Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Painful Diabetic Neuropathy Drug Market Size (2018-2029)
8.2 Asia-Pacific Painful Diabetic Neuropathy Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Painful Diabetic Neuropathy Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Painful Diabetic Neuropathy Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Painful Diabetic Neuropathy Drug Market Size (2018-2029)
9.2 Latin America Painful Diabetic Neuropathy Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023)
9.4 Latin America Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Painful Diabetic Neuropathy Drug Market Size (2018-2029)
10.2 Middle East & Africa Painful Diabetic Neuropathy Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Daiichi Sankyo Company, Limited
11.1.1 Daiichi Sankyo Company, Limited Company Detail
11.1.2 Daiichi Sankyo Company, Limited Business Overview
11.1.3 Daiichi Sankyo Company, Limited Painful Diabetic Neuropathy Drug Introduction
11.1.4 Daiichi Sankyo Company, Limited Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.1.5 Daiichi Sankyo Company, Limited Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Detail
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Painful Diabetic Neuropathy Drug Introduction
11.2.4 Eli Lilly and Company Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.2.5 Eli Lilly and Company Recent Development
11.3 Johnson & Johnson Services, Inc
11.3.1 Johnson & Johnson Services, Inc Company Detail
11.3.2 Johnson & Johnson Services, Inc Business Overview
11.3.3 Johnson & Johnson Services, Inc Painful Diabetic Neuropathy Drug Introduction
11.3.4 Johnson & Johnson Services, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.3.5 Johnson & Johnson Services, Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Painful Diabetic Neuropathy Drug Introduction
11.4.4 Novartis AG Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Painful Diabetic Neuropathy Drug Introduction
11.5.4 Pfizer Inc. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.5.5 Pfizer Inc. Recent Development
11.6 Grunenthal GmbH
11.6.1 Grunenthal GmbH Company Detail
11.6.2 Grunenthal GmbH Business Overview
11.6.3 Grunenthal GmbH Painful Diabetic Neuropathy Drug Introduction
11.6.4 Grunenthal GmbH Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.6.5 Grunenthal GmbH Recent Development
11.7 ViroMed Co.
11.7.1 ViroMed Co. Company Detail
11.7.2 ViroMed Co. Business Overview
11.7.3 ViroMed Co. Painful Diabetic Neuropathy Drug Introduction
11.7.4 ViroMed Co. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.7.5 ViroMed Co. Recent Development
11.8 Collegium Pharmaceutical, Inc
11.8.1 Collegium Pharmaceutical, Inc Company Detail
11.8.2 Collegium Pharmaceutical, Inc Business Overview
11.8.3 Collegium Pharmaceutical, Inc Painful Diabetic Neuropathy Drug Introduction
11.8.4 Collegium Pharmaceutical, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.8.5 Collegium Pharmaceutical, Inc Recent Development
11.9 Acorda Therapeutics, Inc
11.9.1 Acorda Therapeutics, Inc Company Detail
11.9.2 Acorda Therapeutics, Inc Business Overview
11.9.3 Acorda Therapeutics, Inc Painful Diabetic Neuropathy Drug Introduction
11.9.4 Acorda Therapeutics, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.9.5 Acorda Therapeutics, Inc Recent Development
11.10 Zydus Pharmaceuticals
11.10.1 Zydus Pharmaceuticals Company Detail
11.10.2 Zydus Pharmaceuticals Business Overview
11.10.3 Zydus Pharmaceuticals Painful Diabetic Neuropathy Drug Introduction
11.10.4 Zydus Pharmaceuticals Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.10.5 Zydus Pharmaceuticals Recent Development
11.11 Mallinckrodt, Inc
11.11.1 Mallinckrodt, Inc Company Detail
11.11.2 Mallinckrodt, Inc Business Overview
11.11.3 Mallinckrodt, Inc Painful Diabetic Neuropathy Drug Introduction
11.11.4 Mallinckrodt, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.11.5 Mallinckrodt, Inc Recent Development
11.12 Macleods Pharmaceuticals Ltd.
11.12.1 Macleods Pharmaceuticals Ltd. Company Detail
11.12.2 Macleods Pharmaceuticals Ltd. Business Overview
11.12.3 Macleods Pharmaceuticals Ltd. Painful Diabetic Neuropathy Drug Introduction
11.12.4 Macleods Pharmaceuticals Ltd. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.12.5 Macleods Pharmaceuticals Ltd. Recent Development
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Detail
11.13.2 Lupin Pharmaceuticals Business Overview
11.13.3 Lupin Pharmaceuticals Painful Diabetic Neuropathy Drug Introduction
11.13.4 Lupin Pharmaceuticals Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023)
11.13.5 Lupin Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Painful Diabetic Neuropathy Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Others
Table 5. Global Painful Diabetic Neuropathy Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Painful Diabetic Neuropathy Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Painful Diabetic Neuropathy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Painful Diabetic Neuropathy Drug Market Share by Region (2018-2023)
Table 9. Global Painful Diabetic Neuropathy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Painful Diabetic Neuropathy Drug Market Share by Region (2024-2029)
Table 11. Painful Diabetic Neuropathy Drug Market Trends
Table 12. Painful Diabetic Neuropathy Drug Market Drivers
Table 13. Painful Diabetic Neuropathy Drug Market Challenges
Table 14. Painful Diabetic Neuropathy Drug Market Restraints
Table 15. Global Painful Diabetic Neuropathy Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Painful Diabetic Neuropathy Drug Market Share by Players (2018-2023)
Table 17. Global Top Painful Diabetic Neuropathy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Painful Diabetic Neuropathy Drug as of 2022)
Table 18. Ranking of Global Top Painful Diabetic Neuropathy Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Painful Diabetic Neuropathy Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Painful Diabetic Neuropathy Drug Product Solution and Service
Table 22. Date of Enter into Painful Diabetic Neuropathy Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Painful Diabetic Neuropathy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Painful Diabetic Neuropathy Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Painful Diabetic Neuropathy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Painful Diabetic Neuropathy Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Painful Diabetic Neuropathy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Painful Diabetic Neuropathy Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Painful Diabetic Neuropathy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Painful Diabetic Neuropathy Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Painful Diabetic Neuropathy Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Painful Diabetic Neuropathy Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Painful Diabetic Neuropathy Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Painful Diabetic Neuropathy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Painful Diabetic Neuropathy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Painful Diabetic Neuropathy Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Painful Diabetic Neuropathy Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Painful Diabetic Neuropathy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Painful Diabetic Neuropathy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Daiichi Sankyo Company, Limited Company Detail
Table 48. Daiichi Sankyo Company, Limited Business Overview
Table 49. Daiichi Sankyo Company, Limited Painful Diabetic Neuropathy Drug Product
Table 50. Daiichi Sankyo Company, Limited Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 51. Daiichi Sankyo Company, Limited Recent Development
Table 52. Eli Lilly and Company Company Detail
Table 53. Eli Lilly and Company Business Overview
Table 54. Eli Lilly and Company Painful Diabetic Neuropathy Drug Product
Table 55. Eli Lilly and Company Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly and Company Recent Development
Table 57. Johnson & Johnson Services, Inc Company Detail
Table 58. Johnson & Johnson Services, Inc Business Overview
Table 59. Johnson & Johnson Services, Inc Painful Diabetic Neuropathy Drug Product
Table 60. Johnson & Johnson Services, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 61. Johnson & Johnson Services, Inc Recent Development
Table 62. Novartis AG Company Detail
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Painful Diabetic Neuropathy Drug Product
Table 65. Novartis AG Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Pfizer Inc. Company Detail
Table 68. Pfizer Inc. Business Overview
Table 69. Pfizer Inc. Painful Diabetic Neuropathy Drug Product
Table 70. Pfizer Inc. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 71. Pfizer Inc. Recent Development
Table 72. Grunenthal GmbH Company Detail
Table 73. Grunenthal GmbH Business Overview
Table 74. Grunenthal GmbH Painful Diabetic Neuropathy Drug Product
Table 75. Grunenthal GmbH Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 76. Grunenthal GmbH Recent Development
Table 77. ViroMed Co. Company Detail
Table 78. ViroMed Co. Business Overview
Table 79. ViroMed Co. Painful Diabetic Neuropathy Drug Product
Table 80. ViroMed Co. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 81. ViroMed Co. Recent Development
Table 82. Collegium Pharmaceutical, Inc Company Detail
Table 83. Collegium Pharmaceutical, Inc Business Overview
Table 84. Collegium Pharmaceutical, Inc Painful Diabetic Neuropathy Drug Product
Table 85. Collegium Pharmaceutical, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 86. Collegium Pharmaceutical, Inc Recent Development
Table 87. Acorda Therapeutics, Inc Company Detail
Table 88. Acorda Therapeutics, Inc Business Overview
Table 89. Acorda Therapeutics, Inc Painful Diabetic Neuropathy Drug Product
Table 90. Acorda Therapeutics, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 91. Acorda Therapeutics, Inc Recent Development
Table 92. Zydus Pharmaceuticals Company Detail
Table 93. Zydus Pharmaceuticals Business Overview
Table 94. Zydus Pharmaceuticals Painful Diabetic Neuropathy Drug Product
Table 95. Zydus Pharmaceuticals Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 96. Zydus Pharmaceuticals Recent Development
Table 97. Mallinckrodt, Inc Company Detail
Table 98. Mallinckrodt, Inc Business Overview
Table 99. Mallinckrodt, Inc Painful Diabetic Neuropathy Drug Product
Table 100. Mallinckrodt, Inc Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 101. Mallinckrodt, Inc Recent Development
Table 102. Macleods Pharmaceuticals Ltd. Company Detail
Table 103. Macleods Pharmaceuticals Ltd. Business Overview
Table 104. Macleods Pharmaceuticals Ltd. Painful Diabetic Neuropathy Drug Product
Table 105. Macleods Pharmaceuticals Ltd. Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 106. Macleods Pharmaceuticals Ltd. Recent Development
Table 107. Lupin Pharmaceuticals Company Detail
Table 108. Lupin Pharmaceuticals Business Overview
Table 109. Lupin Pharmaceuticals Painful Diabetic Neuropathy Drug Product
Table 110. Lupin Pharmaceuticals Revenue in Painful Diabetic Neuropathy Drug Business (2018-2023) & (US$ Million)
Table 111. Lupin Pharmaceuticals Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Painful Diabetic Neuropathy Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Painful Diabetic Neuropathy Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Others Features
Figure 6. Global Painful Diabetic Neuropathy Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Painful Diabetic Neuropathy Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Painful Diabetic Neuropathy Drug Report Years Considered
Figure 12. Global Painful Diabetic Neuropathy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Painful Diabetic Neuropathy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Painful Diabetic Neuropathy Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Painful Diabetic Neuropathy Drug Market Share by Players in 2022
Figure 16. Global Top Painful Diabetic Neuropathy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Painful Diabetic Neuropathy Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Painful Diabetic Neuropathy Drug Revenue in 2022
Figure 18. North America Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Painful Diabetic Neuropathy Drug Market Share by Country (2018-2029)
Figure 20. United States Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Painful Diabetic Neuropathy Drug Market Share by Country (2018-2029)
Figure 24. Germany Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Painful Diabetic Neuropathy Drug Market Share by Region (2018-2029)
Figure 32. China Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Painful Diabetic Neuropathy Drug Market Share by Country (2018-2029)
Figure 40. Mexico Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Painful Diabetic Neuropathy Drug Market Share by Country (2018-2029)
Figure 44. Turkey Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Painful Diabetic Neuropathy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Daiichi Sankyo Company, Limited Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 47. Eli Lilly and Company Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 48. Johnson & Johnson Services, Inc Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 49. Novartis AG Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 50. Pfizer Inc. Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 51. Grunenthal GmbH Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 52. ViroMed Co. Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 53. Collegium Pharmaceutical, Inc Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 54. Acorda Therapeutics, Inc Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 55. Zydus Pharmaceuticals Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 56. Mallinckrodt, Inc Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 57. Macleods Pharmaceuticals Ltd. Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 58. Lupin Pharmaceuticals Revenue Growth Rate in Painful Diabetic Neuropathy Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs